Merck announces phase 3 study of its COVID-19 drug
Merck & Co. Inc. announced on Wednesday it has started the phase 3 clinical trial of its COVID-19 drug named molnupiravir with biotech company Ridgeback Biotherapeutics.
“As the pandemic con…
Harry T. Partner's Academy & fpmarkets
NOI SIAMO UN GRUPPO DI LAVORO PER QUESTO NON TI CHIEDIAMO SOLDI. CON NOI NON SARAI SOLO
